Accurun 140 Rubella Igg Positive Control
by Boston Biomedica, Inc. United States(FDA 510(k) applicant) 510(k)
510(k) K972986 Product code MJX
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK972986 | Date8 Oct 1997 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MJX
- Device Class
- Class I
- Regulation
- 21 CFR Part 862.1660
- Advisory Committee
- Clinical Chemistry
- FDA Decision
- SESE Substantially Equivalent
Other devices from Boston Biomedica, Inc.
Properties & raw data
Show properties, registry sources and raw records
Sources (1)
- FDA 510(k) K972986